Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04120480 · ClinicalTrials.gov registry record · NA
Effectiveness of PGx Testing
A NA study of Polypharmacy, sponsored by Kaiser Permanente.
- Active
- Registry status
- NA
- Development phase
- 600
- Enrollment target
- 1
- Study location
NCT04120480 is a NA study of Polypharmacy that is active but no longer recruiting, run by Kaiser Permanente. The registered enrollment target is 600 participants, below the 1,526-participant average among 8 other Polypharmacy trials with a reported enrollment target (61% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04120480, a NA study of Polypharmacy, is active but no longer recruiting, sponsored by Kaiser Permanente.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 600 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the clinical and economic effectiveness of a pharmacogenomic (PGx) approach to prescribing medications in patients with high-risk polypharmacy in an integrated healthcare delivery system. Investigators hypothesize that patients who receive the RightMed® PGx test from OneOme, LLC with subsequent counseling of their prescribers by a study pharmacist, as needed, on the appropriateness of their prescribed medications will experience lower one-year follow-up healthcare utilization and expenditures compared to control patients who receive usual care.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Pharmacogenomic test
Study Locations (1)
Colorado
- Central Support Services - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2019-11-15 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04120480
The ClinicalTrials.gov registry entry for NCT04120480 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,526-participant average among 8 other Polypharmacy trials with a reported enrollment target (61% lower). The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Polypharmacy appearing as the primary indexed condition, and to 1 intervention - of which Pharmacogenomic test is the first listed.
NCT04120480 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT04120480 about?
NCT04120480 is a clinical study titled "Effectiveness of PGx Testing". The purpose of this study is to determine the clinical and economic effectiveness of a pharmacogenomic (PGx) approach to prescribing medications in patients with high-risk polypharmacy in an integrated healthcare delivery system. Investigators hypothesize that patients who receive the RightMed® PGx...
What is the current status of trial NCT04120480?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 600 participants. The study started on 2019-11-15. Estimated completion is 2027-12-31.
What conditions does trial NCT04120480 study?
This clinical trial studies the following conditions: Polypharmacy.
What interventions are being tested in trial NCT04120480?
The interventions under investigation include: Pharmacogenomic test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04120480?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04120480 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Polypharmacy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Improving Medication Management in World Trade Center Responders
RECRUITING · NA
-
Reducing High-Risk Geriatric Polypharmacy Via EHR Nudges R01 Trial
ACTIVE NOT RECRUITING · NA
-
Preemptive Pharmacogenomics Testing Among Geriatric Patients
ACTIVE NOT RECRUITING · NA
-
Pharmacist Intervention to Reduce Post-Hospitalization Utilization
ACTIVE NOT RECRUITING · NA
-
A Randomized Controlled Trial to Deprescribe for Older Patients With Polypharmacy
COMPLETED · NA
-
Tailored Medication Management Intervention
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.